Boutique Venture Partners β Full Portfolio
48 tracked investments Β· listed companies and verified rows first
HealthtechSan Francisco, US
Senan Ebrahim(Executive Officer, Director)Isabel Fulcher(Director)
BoardDafina Toncheva(Director)inJacob Yormak(Director)
Co-investorsArtis VenturesBread And Butter Ventures, LlcBread Butter VenturesGoodwater CapitalMetrodora VenturesSpringTime Ventures+3 more
Docbot developed AI-powered software for gastroenterology, using computer vision to detect polyps and assist diagnosis during endoscopy and colonoscopy procedures.
ConsumerGamingHealthtechLos Angeles, US
Tyler Dao(Founder)inWilliam Karnes(Founder)inAndrew Ninh(Founder)in
Co-investorsY CombinatorBold Capital PartnersCollaborative FundKhosla Ventures
Transforming kidney stone removal through next-gen systems
Filtricine is a clinical-stage biotechnology company developing nutrition-based medical food products for disease control, using its Targeted Nutrients Deprivation (TND) approach to starve cancer cells while providing balanced nutrition to patients.
BiotechDigital HealthFoodTechSan Francisco Bay Area, US
Co-investorsBluestein VenturesEvolution VC PartnersSOSV
Frontier Bio develops tissue engineering and bioprinting technology, including fabrication of tissue-engineered blood vessels for clinical and in vitro applications.
BiotechDeep TechMedical Devices
Eric Bennett(CEO)Sam Pashneh-Tala(CTO)
BoardGeorge Church(Scientific Advisor)
Co-investorsArtesianAsymmetry VenturesBrincPortfolia
Genalyte is developing Merlin, an automated diagnostic device that processes blood samples on-site and returns lab results within minutes while the patient waits.
Digital HealthHardwareMedical Devices
Co-investorsBioBritClaremont Creek VenturesFusionX VenturesIPD CapitalSamsara BioCapitalSeed Healthcare+3 more
Handl provides API-based document classification and data extraction using AI, converting documents into structured data for enterprise customers.
AI & Machine LearningData & InfrastructureEnterprise SoftwareFintechSaaSSan Francisco, US
Alexei Hahunov(Founder)inDima Matskevich(Founder)in
Co-investorsY CombinatorArthur VenturesMucker CapitalRiverfront Ventures, LLCZeno Ventures
Handl Health is an AI platform that aggregates publicly available healthcare pricing data to help insurance brokers and benefits consultants optimize health plans and identify cost savings opportunities.
AI & Machine LearningData & InfrastructureHealthtechInsurTechCerritos, US
RiainAishwaria Shah(Executive Officer, Director, Promoter)Ahmed Marmoush(Executive Officer, Director, Promoter)in
BoardRyan Kruizenga(Director)in
Co-investorsArthur VenturesEverywhere VenturesTau VenturesTechstarsMucker CapitalRiverfront Ventures, LLC
Kanvas Bio operates a platform for discovering, developing, and manufacturing live biotherapeutics based on the human gut microbiome.
BiotechDeep TechHealthtechMonmouth Junction, US
Matthew Cheng(Executive Officer, Director)Hao Shi(Executive Officer, Director)Iwijn De Vlaminck(Executive Officer, Director)
BoardJason Pontin(Director)inJustin Smithline(Director)in
Co-investorsBascom VenturesDCVC (Data Collective)FemHealth VenturesGermin8 VenturesKicker VenturesPangaea Ventures Us Inc.+2 more
Kopra Bio develops cancer immunotherapy technology that converts cancer cells into biofactories to produce their own destruction.
BiotechHealthtechMedical DevicesSan Francisco, US
Alexander Haddad(Founder)in
Co-investorsChamaeleonMetaplanetMythos Ventures Management, LlcTranspose Platform ManagementY Combinator
Ovia Health provides digital health tools and clinical programs for reproductive and family health, including fertility, pregnancy, and parenthood support.
Digital HealthFemTechHealthtechWellness & FitnessBoston, US
Alex Baron(Founder)in
Co-investorsForeground CapitalLightbankLionBirdMartin VenturesTechstars
Ithaca, US
Gregory Galvin(Executive Officer)Gregory J Galvin(Executive Officer)Anthony Eisenhut(Executive Officer)John Brenner(Executive Officer)Christopher Smith(Executive Officer)John Albert Brenner(Executive Officer)
Co-investorsCayuga Venture FundRand Capital
Co-investorsOUP (Osage University Partners)venBio Partners
Sion Power develops lithium-metal batteries through its patented Licerion platform, offering high energy-density cells for defense, aerospace, and electric vehicle applications.
CleantechEnergyNew MaterialsTucson, US
TRACY KELLEY(Chief Executive Officer)MARK SMITH(Chief Financial Officer)Pamela Fletcher(CEO)Mitch Hourtienne(Chief Commercial Officer)Tracy Kelley(President & Chief Science Officer)Job Rijssenbeek(CTO)
Co-investorsLG Technology Ventures
Surge developed an immune profiling approach intended to identify patients at risk for post-surgical complications
Company operating a biomarker discovery platform (Stabl) that applies multiomics, systems biology, and machine learning to extract clinically actionable biomarkers from complex datasets.
AI & Machine LearningBiotechDigital Health
Clinical-stage biotech expanding the genetic alphabet with synthetic nucleotides; acquired by Sanofi for $2.5B in 2020.
BiotechLa Jolla, US
Jay Lichter(Director)Douglas Downs(Executive Officer)Floyd Romesberg(Director)Court Turner(Executive Officer, Director)
Co-investorsAvalon BioVenturesCorrelation VenturesOUP (Osage University Partners)RA CapitalvenBio Partners
Data-driven medical insights for optimal postoperative recovery
BiotechSan Carlos, US
Surag Mantri(Executive Officer, Director)
BoardJustin Klein(Director)inMatthew Sprinkel(Director)Amir Abolfathi(Director)Varun Gupta(Director)
Co-investorsLongitude CapitalNeotribe VenturesVensana Capital
Rows marked βSEC filingβ are inferred from directors named on the company's SEC Form D β public regulatory data, not a portfolio list published by the firm.